{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:23:08Z","timestamp":1761016988537},"reference-count":28,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T00:00:00Z","timestamp":1343260800000},"content-version":"vor","delay-in-days":11195,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[1981,12]]},"abstract":"<jats:p>1 A single 500 micrograms oral dose of prazosin was associated with significant suppression of sympathetically mediated venoconstriction, as measured by the venous reflex response in six healthy volunteers. 2 The impaired venous reflex response consistently preceded orthostatic hypotension and tachycardia, which were associated with faintness and other unpleasant symptoms. 3 The plasma prazosin concentration, which was measured by a sensitive, specific h.p.l.c. assay, varied appreciably both between and within individual subjects. 4 There was no precise relationship between the plasma prazosin concentration and the symptomatic haemodynamic effects observed. 5 It was concluded that reduced venous return to the heart, due to significant suppression of sympathetically mediated venoconstriction by small initial oral dosage of prazosin, contributes to the pathophysiology of the orthostatic hypotension and faintness, described as the \u2018first\u2010dose phenomenon\u2019.<\/jats:p>","DOI":"10.1111\/j.1365-2125.1981.tb01324.x","type":"journal-article","created":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T16:35:24Z","timestamp":1343320524000},"page":"873-881","source":"Crossref","is-referenced-by-count":9,"title":["The effect of a single oral dose of prazosin on venous reflex response, blood pressure and pulse rate in normal volunteers."],"prefix":"10.1111","volume":"12","author":[{"given":"GJ","family":"Schapel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WH","family":"Betts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,26]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt197722179"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00562058"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5973.727-a"},{"key":"e_1_2_1_5_1","first-page":"125","article-title":"The deep breathvenoconstriction reflex","volume":"37","author":"BROWSE N.L.","year":"1969","journal-title":"Clin. Sc."},{"key":"e_1_2_1_6_1","first-page":"144","article-title":"In vitro relaxation of arteries and veins by prazosin: Alpha\u2010adrenergic blockade with no direct vasodilation","volume":"16","author":"COHEN M.L.","year":"1979","journal-title":"Blood Vessels."},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1978.tb01595.x"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.3109\/10641967809068604"},{"key":"e_1_2_1_9_1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5694\/j.1326-5377.1980.tb125811.x","article-title":"Aspects of the pharmacology of prazosin","volume":"2","author":"DAVEY M.J.","year":"1980","journal-title":"Med. J. Aust."},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198005060-00007"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.37.4.524"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6047.1293"},{"key":"e_1_2_1_13_1","first-page":"81","article-title":"The action of prazosin in human vascular preparations","volume":"231","author":"JAUERNIG R.A.","year":"1978","journal-title":"Arch. int. Pharmacodyn."},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5694\/j.1326-5377.1980.tb125813.x","article-title":"Prediction of response to antihypertensive therapy with prazosin","volume":"2","author":"MacCARTHY E.P.","year":"1980","journal-title":"Med. J. Aust."},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01907641"},{"key":"e_1_2_1_16_1","first-page":"155","volume-title":"Clinical Pharmacology. Basic Principles in Therapeutics","author":"NIES A.S.","year":"1978"},{"key":"e_1_2_1_17_1","first-page":"282","article-title":"Relationship between the hypotensive and alpha\u2010adrenoceptor blocking actions of prazosin","volume":"23","author":"OATES H.F.","year":"1979","journal-title":"Arch. int. Pharmacodyn."},{"key":"e_1_2_1_18_1","first-page":"224","article-title":"Comparison of the in vitro effects of prazosin, difedipine and dihydralazine in isolated human mesenteric and crural vessels","volume":"241","author":"PEDERSEN O.L.","year":"1979","journal-title":"Arch. int. Pharmacodyn."},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)92526-6"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)81024-5"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6034.508"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1980.tb00498.x"},{"key":"e_1_2_1_23_1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1152\/jappl.1966.21.1.341","article-title":"Temporary arrest of circulation to a limb for the study of venomotor reactions in man","volume":"21","author":"SAMUELOFF S.L.","year":"1966","journal-title":"J. appl. Physiol."},{"key":"e_1_2_1_24_1","first-page":"247","article-title":"Role of the venous system in circulatory control","volume":"53","author":"SHEPHERD J.T.","year":"1978","journal-title":"Mayo Clin. Proc."},{"key":"e_1_2_1_25_1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5694\/j.1326-5377.1977.tb107756.x","article-title":"Use of prazosin at the Dunedin hypertension clinic. Controlled and open studies and pharmacokinetic observations","volume":"2","author":"SIMPSON F.O.","year":"1977","journal-title":"Med. J. Aust."},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6075.1507"},{"key":"e_1_2_1_27_1","first-page":"41","article-title":"Prazosin: new alpha\u2010adrenergic blocking agent in treatment of hypertension","volume":"3","author":"STOKES G.S.","year":"1978","journal-title":"Cardiovasc. Med."},{"key":"e_1_2_1_28_1","first-page":"286","article-title":"Prazosin in hypertension. Part II Effects of the initial dose","volume":"86","author":"TURNER A.S.","year":"1977","journal-title":"N.Z. med. J."},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1975185part1571"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.1981.tb01324.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.1981.tb01324.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T15:33:22Z","timestamp":1699716802000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.1981.tb01324.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1981,12]]}},"alternative-id":["10.1111\/j.1365-2125.1981.tb01324.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.1981.tb01324.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,12]]}}}